Current:Home > StocksFDA advisers support approval of RSV vaccine to protect infants -Trailblazer Capital Learning
FDA advisers support approval of RSV vaccine to protect infants
View
Date:2025-04-14 01:20:26
Advisers to the Food and Drug Administration recommended that the agency should approve the first vaccine to protect infants from RSV, or respiratory syncytial virus. But some of the experts expressed reservations about the adequacy of data in support of the vaccine's safety.
In a two-part vote, the experts voted unanimously, 14-0, that the available data support the effectiveness of the Pfizer vaccine in preventing severe RSV-related respiratory illness. They then voted 10-4 that the data supports the vaccine's safety.
RSV is a leading cause of infant hospitalization in the U.S. From 58,000 to 80,000 children younger than 5 years old are hospitalized each year with RSV infections, according to the Centers for Disease Control and Prevention. Infants 6 months old and younger are at elevated risk for severe RSV illness.
The votes came after a day of testimony and discussion during a public meeting of the agency's expert panel on vaccines. The FDA isn't bound to follow the advice of its expert panels, but it usually does. A decision on the vaccine for infants is expected by late August.
The vaccine isn't given to babies. Instead, pregnant people are immunized during the late second to third trimester of pregnancy. The antibodies they develop against RSV pass to the fetus in the womb and later protect the newborn.
A clinical study involving 7,400 people found the vaccine had 81.8% efficacy in preventing severe respiratory illness caused by RSV within three months after birth and 69.4% in the first six months.
There was some evidence that those who got vaccinated might have been more likely to give birth prematurely. And committee members worried about pregnant people getting the vaccine at the same time as some other vaccines, such as TDAP (tetanus-diphtheria-pertussis), because it could interfere with their effectiveness.
"I worry that if preterm births are in any way a consequence of this vaccine, that would be tragic," said Dr. Paul Offit, professor of pediatrics at The Children's Hospital of Philadelphia. He voted no on the adequacy of safety data.
The same Pfizer vaccine is under FDA review to protect people 60 and older people from RSV. Advisers voted to support approval of the vaccine at February meeting.
Separately, in a first, the agency approved an RSV vaccine from drugmaker GSK in early May for people 60 and older.
veryGood! (35223)
Related
- Newly elected West Virginia lawmaker arrested and accused of making terroristic threats
- Polluting Industries Cash-In on COVID, Harming Climate in the Process
- In Setback to Industry, the Ninth Circuit Sends California Climate Liability Cases Back to State Courts
- For the Sunrise Movement’s D.C. Hub, a Call to Support the Movement for Black Lives
- Spooky or not? Some Choa Chu Kang residents say community garden resembles cemetery
- Binance was once FTX's rival and possible savior. Now it's trying not to be its sequel
- Trump says he'd bring back travel ban that's even bigger than before
- The Best Protection For Forests? The People Who Live In Them.
- Tom Holland's New Venture Revealed
- U.S. opens new immigration path for Central Americans and Colombians to discourage border crossings
Ranking
- All That You Wanted to Know About She’s All That
- Elon Musk is using the Twitter Files to discredit foes and push conspiracy theories
- Video: Access to Nature and Outdoor Recreation are Critical, Underappreciated Environmental Justice Issues
- Taylor Lautner’s Response to Olivia Rodrigo’s New Song “Vampire” Will Make Twihards Howl
- 2 killed, 3 injured in shooting at makeshift club in Houston
- Deep Decarbonization Plans for Michigan’s Utilities, but Different Paths
- Super-Polluting Methane Emissions Twice Federal Estimates in Permian Basin, Study Finds
- RHONJ: Teresa Giudice and Joe Gorga Share Final Words Before Vowing to Never Speak Again
Recommendation
Military service academies see drop in reported sexual assaults after alarming surge
Target recalls weighted blankets after reports of 2 girls suffocating under one
After the Fukushima disaster, Japan swore to phase out nuclear power. But not anymore
Twitter suspends several journalists who shared information about Musk's jet
Macy's says employee who allegedly hid $150 million in expenses had no major 'impact'
Washington Commits to 100% Clean Energy and Other States May Follow Suit
Video: Access to Nature and Outdoor Recreation are Critical, Underappreciated Environmental Justice Issues
Kristen Stewart and Fiancée Dylan Meyer's New Film Will Have You Flying High